Cargando…
Functional characterization of NPM1–TYK2 fusion oncogene
Gene fusions are known to drive many human cancers. Therefore, the functional characterization of newly discovered fusions is critical to understanding the oncobiology of these tumors and to enable therapeutic development. NPM1–TYK2 is a novel fusion identified in CD30 + lymphoproliferative disorder...
Autores principales: | Kuravi, Sudhakiranmayi, Baker, Riley W., Mushtaq, Muhammad Umair, Saadi, Irfan, Lin, Tara L., Vivian, Carolyn J., Valluripalli, Anusha, Abhyankar, Sunil, Ganguly, Siddhartha, Cui, Wei, Elenitoba-Johnson, Kojo S. J., Welch, Danny R., Jensen, Roy A., Saunthararajah, Yogen, McGuirk, Joseph P., Balusu, Ramesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766497/ https://www.ncbi.nlm.nih.gov/pubmed/35042970 http://dx.doi.org/10.1038/s41698-021-00246-4 |
Ejemplares similares
-
CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas
por: Kuravi, Sudhakiranmayi, et al.
Publicado: (2019) -
Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients
por: Mushtaq, Muhammad Umair, et al.
Publicado: (2021) -
Bendamustine Associated with Irreversible Ascending Paralysis
por: Alhafez, Ashraf, et al.
Publicado: (2013) -
Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma
por: Subbiah, V., et al.
Publicado: (2021) -
Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer
por: Sekhar, Konjeti R., et al.
Publicado: (2022)